4880 Share Price Performance
JP¥0
-679.00 (-100.00%)
Price JP¥0
Share Pricen/a
Analysis Article • Dec 16
CellSource Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4880 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
CellSource Co., Ltd. Key Details
Last Reported Earnings
Jan 31, 2026
Next Reporting Earnings
Jun 10, 2026
- 4.49
- 57.24%
- 2.39%
- 0%
About 4880
- Founded
- 2015
- Employees
- 148
- CEO
- WebsiteView website
CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients’ adipose tissues, and to prepare platelet-rich plasma from patients’ blood; and offers support services for medical facilities providing regenerative medicine therapy. It is also involved in the sale of human stem cell-derived cosmetic ingredients; and Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Shibuya, Japan.
